Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
HEALTH
November 22, 202013 min read, 2636 words

Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use AuthorizationRegeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization

Published: November 22, 2020  |  13 min read, 2636 words
× -- OR --  [21-November-2020] , /PRNewswire/ --First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2Authorized for recently diagnosed, mild to moderate COVID-19 in high-risk patientsInitial doses of REGEN...
Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.